Alcami Corp., a pharmaceutical and biotech contract development and manufacturing organization (CDMO), has completed the acquisition of Masy Systems Inc., a provider of cGMP biostorage and pharma support services. Financial terms were not disclosed.
 
Masy was founded in 1984 by entrepreneurs Laurie and John Masiello and operates three cGMP Biostorage facilities in Massachusetts, near Boston and Cambridge, with a fourth facility coming online in early 2022. The company offers secure and tightly controlled cGMP temperature storage from -196˚C to 70˚C, including all ICH stability conditions, for various materials including vaccines, biopharmaceuticals, cell banks, tissues, compounds, and medical devices. The company’s pharma support services include equipment calibration, large-scale validation and qualification projects, SenseAnywhere monitoring solutions, and validation and calibration equipment sales and rentals.
 
Masy’s additional pharma support service operations are located in California, Pennsylvania, New Jersey, and North Carolina.
 
Masy clients will gain access to Alcami’s service offerings ranging from analytical development and testing to full drug product development and manufacturing, both sterile fill-finish and oral solid dose. Similarly, Alcami’s client base will have access to Masy’s cGMP Biostorage capacity and pharma support services.

“The acquisition of Masy adds complementary service offerings and further reinforces Alcami’s ambitious growth and expansion initiatives,” said Patrick D. Walsh, Chairman and CEO of Alcami. 
 
“We built an amazing company at Masy and are thrilled to partner with the Alcami team, as our combined resources and capabilities will result in enhanced support for our customers,” commented Masy co-founder Laurie Masiello. In addition, Steve Lane will continue in his current executive leadership role at Masy and commented, “I look forward to the successful integration and continuing to build a strong and enduring business.”